Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021;44(Suppl. 1):S15–S33
Open Access
- 16 June 2021
- journal article
- correction
- Published by American Diabetes Association in Diabetes Care
- Vol. 44 (9) , 2182
Abstract
Section 2, Classification and Diagnosis of Diabetes, of the Standards of Medical Care in Diabetes—2021 has been annotated to include evidence from a trial on anKeywords
This publication has 2 references indexed in Scilit:
- Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individualsScience Translational Medicine, 2021
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 DiabetesNew England Journal of Medicine, 2019